Abstract | BACKGROUND: OBJECTIVE: To determine the relationship between baseline sLRP1/sRAGE and early cognitive decline in a longitudinal study and explore the possible effect of apolipoprotein E ( APOE) on their association. METHODS: Cognitively normal subjects were followed-up for 4 years. The baseline plasma levels of sLRP1 and sRAGE were measured using commercial ELISA kits. Global cognition was evaluated by Mini-Mental State Examination (MMSE), and cognitive decline was defined as a ≥2-point decrease of MMSE after 4 years. The association between baseline sLRP1/sRAGE and 4-year cognitive decline were analyzed using logistic regression analysis. Interaction analysis was performed to discover the potential effect of APOE genotype on the relationship. RESULTS: 769 participants were included in the final analysis, with 122 subjects (15.86%) were cognitive decline. Baseline sLRP1/sRAGE levels were not associated with 4-year cognitive decline after multivariable adjustments in the total cohort. However, there was significant interaction effect between sRAGE and APOE genotype on cognitive decline (adjusted odds ratio [OR] = 2.09, 95% confidence interval [CI]: 1.13-3.86, p = 0.019). Lower levels of sRAGE were associated with increased risk of cognitive decline among APOE ɛ4 non-carriers (adjusted OR = 1.60, 95% CI: 1.04-2.48, p = 0.034). CONCLUSION: Individuals with lower levels of sRAGE had an increased risk of 4-year cognitive decline in APOE ɛ4 non-carriers, indicating that the association between sRAGE and cognitive decline might depend on the APOE genotype. However, the specific mechanisms need to be further elucidated.
|
Authors | Ling Gao, Liangjun Dang, Shan Wei, Ningwei Hu, Fan Gao, Wei Peng, Suhang Shang, Yi Zhao, Chen Chen, Xiaojuan Guo, Kang Huo, Jingyi Wang, Jin Wang, Qiumin Qu |
Journal | Journal of Alzheimer's disease : JAD
(J Alzheimers Dis)
Vol. 86
Issue 2
Pg. 801-812
( 2022)
ISSN: 1875-8908 [Electronic] Netherlands |
PMID | 35124644
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Amyloid beta-Peptides
- Apolipoprotein E4
- Apolipoproteins E
- Carrier Proteins
- Receptor for Advanced Glycation End Products
- sRAGE protein, human
|
Topics |
- Amyloid beta-Peptides
(metabolism)
- Apolipoprotein E4
(genetics, metabolism)
- Apolipoproteins E
(genetics)
- Carrier Proteins
(genetics)
- Cognitive Dysfunction
(diagnosis, genetics)
- Genotype
- Humans
- Longitudinal Studies
- Receptor for Advanced Glycation End Products
(blood)
|